IP Library › Assignment 039103/0203
Patent Assignment
Reel/Frame 039103/0203

Assignment of Assignor's Interest

Recorded: 2016-07-07 Pages: 10
Assignor
TABUTEAU, HERRIOT
Executed: 2016-06-14
Assignee
ANTECIP BIOVENTURES II LLC
630 FIFTH AVENUE, SUITE 2000, NEW YORK, NEW YORK, 10111
Covered Properties (14)
Compositions Comprising Zoledronic Acid or Related Compounds for Treatment of Complex Regional Pain Syndrome
Application: 15/014,994 →
Publication: US US20160151398A1
Dosage Forms For Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease
Patent: 9,585,901 →
Application: 15/042,017 →
Publication: US US20160158254A1
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Paget's Disease of Bone
Patent: 9,585,902 →
Application: 15/043,141 →
Publication: US US20160158255A1
Dosage Forms for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease
Patent: 9,517,242 →
Application: 15/043,281 →
Publication: US US20160158256A1
Compositions Comprising Rank/Rankl Antagonists and Related Compounds for Treating Pain
Application: 15/043,419 →
Publication: US US20160166590A1
Bupropion as a Modulator of Drug Activity
Patent: 9,408,815 →
Application: 15/057,983 →
Publication: US US20160199321A1
Osteoclast Inhibitors for Knee Conditions
Patent: 9,522,157 →
Application: 15/074,367 →
Publication: US US20160199394A1
Osteoclast Inhibitors for Knee Conditions
Patent: 9,623,037 →
Application: 15/074,380 →
Publication: US US20160199395A1
Dosage Forms for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease
Patent: 9,616,077 →
Application: 15/083,105 →
Publication: US US20160206636A1
Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects
Patent: 9,421,176 →
Application: 15/130,807 →
Publication: US US20160228390A1
Dosage Forms for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease
Patent: 9,616,078 →
Application: 15/136,092 →
Publication: US US20160235772A1
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome
Application: 15/188,725 →
Publication: US US20160296539A1
Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects
Patent: 9,474,731 →
Application: 15/182,253 →
Publication: US US20160317476A1
Compositions Comprising Rank/Rankl Antagonists and Related Compounds for Treating Pain
Patent: 9,493,571 →
Application: 15/182,378 →
Publication: US US20160289330A1
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 12, 2016
From: TABUTEAU, HERRIOT
To: ANTICEP BIOVENTURES II LLC
Reel/Frame 038578/0839 →
Assignment of Assignor's Interest Jun 24, 2016
From: TABUTEAU, HERRIOT
To: ANTICEP BIOVENTURES II LLC
Reel/Frame 039005/0001 →
Corrective Assignment to Correct the Spelling of the Assignee's Name on the Coversheet Previously Recorded at Reel: 039005 Frame: 0001. Assignor(S) Hereby Confirms the Assignment. Jun 29, 2016
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 039206/0481 →
Corrective Assignment to Correct the Spelling of the Receiving Party Name Previously Recorded on Reel 039005 Frame 0001. Assignor(S) Hereby Confirms the Assignment. Jul 19, 2016
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 039391/0585 →